1. Home
  2. EDSA vs GSUN Comparison

EDSA vs GSUN Comparison

Compare EDSA & GSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • GSUN
  • Stock Information
  • Founded
  • EDSA 2015
  • GSUN 1997
  • Country
  • EDSA Canada
  • GSUN China
  • Employees
  • EDSA N/A
  • GSUN N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • GSUN Other Consumer Services
  • Sector
  • EDSA Health Care
  • GSUN Real Estate
  • Exchange
  • EDSA Nasdaq
  • GSUN Nasdaq
  • Market Cap
  • EDSA 17.2M
  • GSUN 6.1M
  • IPO Year
  • EDSA N/A
  • GSUN 2022
  • Fundamental
  • Price
  • EDSA $2.40
  • GSUN $2.92
  • Analyst Decision
  • EDSA Strong Buy
  • GSUN
  • Analyst Count
  • EDSA 2
  • GSUN 0
  • Target Price
  • EDSA $13.00
  • GSUN N/A
  • AVG Volume (30 Days)
  • EDSA 16.6K
  • GSUN 7.1K
  • Earning Date
  • EDSA 08-08-2025
  • GSUN 09-26-2025
  • Dividend Yield
  • EDSA N/A
  • GSUN N/A
  • EPS Growth
  • EDSA N/A
  • GSUN N/A
  • EPS
  • EDSA N/A
  • GSUN N/A
  • Revenue
  • EDSA N/A
  • GSUN $25,314,724.00
  • Revenue This Year
  • EDSA N/A
  • GSUN N/A
  • Revenue Next Year
  • EDSA N/A
  • GSUN N/A
  • P/E Ratio
  • EDSA N/A
  • GSUN N/A
  • Revenue Growth
  • EDSA N/A
  • GSUN 526.22
  • 52 Week Low
  • EDSA $1.55
  • GSUN $1.82
  • 52 Week High
  • EDSA $5.00
  • GSUN $8.79
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 53.67
  • GSUN 55.00
  • Support Level
  • EDSA $2.41
  • GSUN $2.79
  • Resistance Level
  • EDSA $2.48
  • GSUN $3.00
  • Average True Range (ATR)
  • EDSA 0.09
  • GSUN 0.13
  • MACD
  • EDSA -0.01
  • GSUN 0.00
  • Stochastic Oscillator
  • EDSA 51.85
  • GSUN 68.93

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About GSUN Golden Sun Education Group Limited

Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.

Share on Social Networks: